Publication | Year | ||||||||
---|---|---|---|---|---|---|---|---|---|
Authors :
Ryohei Osako
, Naoki Matsumaru
, Katsura Tsukamoto
Journal : Therapeutic Innovation & Regulatory Science Journal Reference count : 31 |
2024 | ||||||||
Authors :
Gentaro Tajima
, Naoki Matsumaru
, Katsura Tsukamoto
Journal : Journal of Clinical Pharmacy and Therapeutics Journal Reference count : 32 Volume : 47 Pages : 1395-1401 |
2022 | ||||||||
Authors :
Keiichi Sawachi
, Naoki Matsumaru
, Katsura Tsukamoto
Journal : Journal of Clinical Pharmacy and Therapeutics Journal Reference count : 21 Volume : 47 Pages : 1388-1394 |
2022 | ||||||||
Characteristics of drugs approved in Japan without conducting confirmatory clinical trials Authors : Shunsuke Izuka , Naoki Matsumaru , Katsura TsukamotoJournal : Journal of Clinical Pharmacy and Therapeutics Journal Reference count : 13 Volume : 46 Pages : 1582-1590 |
2021 | ||||||||
Influence of Expedited Programs in the United States on Oncology Drug Development in Japan Authors : Makoto Tanaka , Naoki Matsumaru , Katsura TsukamotoJournal : Therapeutic Innovation & Regulatory Science Journal Reference count : 28 Volume : 53 Pages : 199-206 |
2019 | ||||||||
Health Technology Assessment in Japan: A Pharmaceutical Industry Perspective Authors : Kaori Kido , Naoki Matsumaru , Katsura TsukamotoJournal : Therapeutic Innovation & Regulatory Science Journal Reference count : 15 Volume : 53 Pages : 472-480 |
2019 | ||||||||
Japan's health care system faces a perfect storm Authors : Kaori Kido , Katsura TsukamotoJournal : The International Journal of Health Planning and Management Journal Reference count : 34 Volume : 35 |
2019 | ||||||||
Safety-Related Regulatory Actions and Risk Factors for Anticancer Drugs in Japan Authors : Hiroki Nakayama , Naoki Matsumaru , Katsura TsukamotoJournal : Pharmaceutical Medicine Journal Reference count : 22 Volume : 33 Pages : 45-52 |
2018 | ||||||||
Authors :
Hiroki Nakayama
, Naoki Matsumaru
, Katsura Tsukamoto
Journal : Investigational New Drugs Journal Reference count : 22 Volume : 37 Pages : 1086-1093 |
2018 | ||||||||
Authors :
Hiroki Nakayama
, Naoki Matsumaru
, Katsura Tsukamoto
Journal : Pharmaceutical Medicine Journal Reference count : 30 Volume : 32 Pages : 403-412 |
2018 | ||||||||
Authors :
Makoto Tanaka
, Naoki Matsumaru
, Katsura Tsukamoto
Journal : Pharmaceutical Medicine Journal Reference count : 31 Volume : 32 Pages : 201-207 |
2018 | ||||||||
Authors :
Mitsuhiro Rokuda
, Naoki Matsumaru
, Katsura Tsukamoto
Journal : Clinical Therapeutics Journal Reference count : 30 Volume : 40 Pages : 284-295 |
2018 | ||||||||
Authors :
Hiroki Nakayama
, Katsura Tsukamoto
Journal : Investigational New Drugs Journal Reference count : 19 Volume : 36 Pages : 702-708 |
2018 | ||||||||
VP71 Health Technology Assessment In Japan: Current Issues And Challenges Authors : Kaori Kido , Naoki Matsumaru , Katsura TsukamotoJournal : International Journal of Technology Assessment in Health Care Volume : 33 Pages : 182-183 |
2017 | ||||||||
Authors :
Masashi Kikuchi
, Naoki Matsumaru
, Katsura Tsukamoto
Journal : Alzheimer's & Dementia Volume : 13 |
2017 | ||||||||
Role of Academia in Regulatory Science for Global Drug Development Authors : Katsura Tsukamoto , Toichi TakenakaJournal : YAKUGAKU ZASSHI Journal Reference count : 10 Volume : 136 Pages : 543-547 |
2016 | ||||||||
Pharmacology and regulatory science foresee drug development Authors : Katsura TsukamotoJournal : Folia Pharmacologica Japonica Journal Reference count : 5 Volume : 148 Pages : 4-8 |
2016 | ||||||||
Authors :
Katsura Tsukamoto
Journal : Clinical Therapeutics Journal Reference count : 31 Volume : 37 Pages : 1652-1660 |
2015 |